(Q35994388)

English

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Lissoni P

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Tisi E

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Barni S

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ardizzoia A

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Rovelli F

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Rescaldani R

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ballabio D

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Benenti C

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Angeli M

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Tancini G

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 July 1992

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

66

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

155-158

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

2 October 2017

Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

2 October 2017

Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

2 October 2017

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

11 July 2018

Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

11 July 2018

Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977913

23 September 2018

Endocrine and immune effects of melatonin therapy in metastatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced non-small-cell lung cancer: to treat or not to treat?

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation and suppression of somatomedin activity by serotonin and melatonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of melatonin on experimental tumors under different photoperiods and times of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of natural killer activity by human bronchoalveolar macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/1322155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1992.234

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35994388&oldid=2198045526"